The DOI matches its Crossref record.
Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis
Open accessAbstract
Wegener's granulomatosis is necrotizing granulomatous vasculitis of unknown origin, which untreated has a high mortality within the first year of onset. The introduction of corticosteroids and cyclophosphamide in the treatment has considerably improved survival rates, but past studies have indicated an increased cancer risk, including an increased risk for urinary bladder cancer. No large assessment of the general cancer occurrence in Wegener's granulomatosis has been reported. The aim of our study was to assess the general incidence of cancer in patients with Wegener's granulomatosis and to put this in relation to the risk for bladder cancer. We identified a population‐based cohort of 1,065 patients with Wegener's granulomatosis in the Swedish In‐patient Register. Through linkage with the Swedish Cancer Register, we followed the cohort for cancer occurrence for up to 26 years. Standardized incidence ratios (SIR) between observed and expected numbers of cancers were used as a measure of relative risk. There was a 2‐fold overall increased risk for cancer in the cohort. The increase was most pronounced for bladder cancer (SIR = 4.8; 95% CI 2.6–8.1), squamous cell skin cancer (SIR = 7.3; 95% CI 4.4–12), leukemias (SIR = 5.7; 95% CI 2.3–12) and for malignant lymphomas (SIR = 4.2; 95% CI 4.2–8.3). The results confirm previous indications of an increased risk for cancer of the urinary bladder but also points to increased risks for cancer at other sites. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Self-citationEULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223764 · Cited by 768
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype
Smedby, K. E., Hjalgrim, H., Askling, J., Chang, E. T., Gregersen, H., Porwit-MacDonald, A., Sundström, C., Åkerman, M., Melbye, M., Glimelius, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj004 · Cited by 439
Self-citationHolle, J. U., Gross, W. L., Latza, U., Nölle, B., Ambrosch, P., Heller, M., Fertmann, R., & Reinhold‐Keller, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.27763 · Cited by 270
Epidemiology of urinary bladder cancer: from tumor development to patient’s death
Murta-Nascimento, C., Schmitz-Dräger, B. J., Zeegers, M. P., Steineck, G., Kogevinas, M., Real, F. X., & Malats, N. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0168-5 · Cited by 254
Metadata
- Authors
- Knight, A., Askling, J., & Ekbom, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-05-29
- Volume
- 100
- Issue
- 1
- Pages
- 82-85
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2097201764
- Cited by
- 199
- References
- 0
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis. https://app.cochat.ai/papers/10.1002/ijc.10444
- The paper
- Knight, A., Askling, J., & Ekbom, A. (2002). Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis. International Journal of Cancer. https://doi.org/10.1002/ijc.10444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.